Latest Headlines

  1. Siemens Healthineers Hemoglobin A1c Test For Diagnosing And Monitoring Diabetes Now Available On The Atellica Solution

    Siemens Healthineers announced today the global availability of its new Atellica CH Enzymatic Hemoglobin A1c (A1c_E) Assay to assist clinicians in diagnosing and monitoring diabetes, a growing and potentially deadly disease

  2. South Africa Invests In Flow Chemistry

    Uniqsis reports on two major orders for its FlowSyn flow chemistry systems from organisations involved with the South African Pharmaceutical Industry

  3. SpeeDx Receives Clearance For PlexPCR Respiratory Virus Test

    SpeeDx Pty. Ltd. recently announced the clearance of the PlexPCR RespiVirus test from the Australian Therapeutic Goods Administration (TGA)

  4. GRAIL Announces Significant Progress With Multi-Cancer Early Detection Test Including FDA Breakthrough Device Designation

    GRAIL, Inc., a healthcare company whose mission is to detect cancer early, when it can be cured, recently announced that its multi-cancer test has been granted Breakthrough Device designation from the U.S. Food and Drug Administration (FDA)

  5. Bruker And Champalimaud Foundation Announce Collaboration To Develop Novel Ultra-High Field 18 Tesla Preclinical MRI System And Applications

    At the Annual Meeting of the International Society for Magnetic Resonance in Medicine (ISMRM), Bruker today announced an agreement to develop the world's first 18 Tesla 11 cm bore, preclinical ultra-high field (UHF) magnetic resonance imaging (MRI) system and its clinical research applications in collaboration with the Champalimaud Foundation

  6. HempAmericana Commences Bottling On Full Spectrum Distillate CBD In Maine Laboratory

    HempAmericana, Inc. (OTC: HMPQ) (“HempAmericana” or the “Company”) is pleased to announce that it has commenced bottling 500mg and 1000mg full spectrum CBD distillate in the Company’s Augusta, Maine laboratory

  7. Anixa Biosciences Announces Completion Of Cchek™ Analytical Verification At CLIA Laboratory

    Anixa Biosciences, Inc. (NASDAQ: ANIX), a biotechnology company focused on harnessing the body's immune system to fight cancer, today announced that its Cchek™ Prostate Cancer Confirmation (Cchek™ PCC) test successfully passed all required initial analytical verification studies en route to commercialization and implementation in the ResearchDx facility

  8. LabCorp Announces Availability Of New QIAGEN therascreen FGFR Mutation Analysis Companion Diagnostic For Bladder Cancer

    LabCorp, a leading global life sciences company that is deeply integrated in guiding patient care, recently announced the availability of a newly-approved companion diagnostic by the U.S. Food and Drug Administration (FDA), the therascreen FGFR mutation assay by RGQ RT-PCR, which is now available for ordering from LabCorp and its Integrated Oncology specialty laboratory

  9. Hitachi High-Tech Science Launches The 'NEXTA STA Series' Thermal Analyzer

    Hitachi High-Technologies Corporation announced recently that its wholly owned subsidiary and analytical instrument manufacturer and marketer Hitachi High-Tech Science Corporation (HHT Science) has developed the new “NEXTA STA Series” of thermal analyzers

  10. Franek Technologies Announces Certified Category III-3 Instrumentation Grade Laboratory Protection Systems For The Applied Biocode Mdx 3000

    Franek Technologies has configured an uninterruptible power supply unit to support the Applied BioCode MDx 3000